QTREX Quantum Ltd. (QTEX): R&D Expense
$7.50M
Year ended 2025-12-31
-2.9%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.50M | +18.6% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $6.32M | -13.6% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $7.32M | -10.5% | 2026-03-26, From 2023-01-01 |
| 2022-12-31 | $8.18M | +101.1% | 2025-03-28, From 2022-01-01 |
| 2021-12-31 | $4.07M | n/a | 2024-03-25, From 2021-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $7.50M | +18.6% |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $44.72M | +38.3% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $862.0K | +216.9% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.59M | -11.8% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
| Vivos Inc (RDGL) | 2025-12-31 | $352.2K | +8.5% |
Compare QTEX, PLSE, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗